Paper4584690
Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.
Grunberg E and 1 other. Annu Rev Microbiol, 1973. Cited by 87 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings. Papers, record 4584690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4584690
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heterocyclic Compounds | Major topic |
| Nitro Compounds | Major topic |
| Nitrofurans | Major topic |
| Nitroimidazoles | Major topic |
| Thiazoles | Major topic |
| Bacteria | |
| Bacterial Infections | |
| Helminthiasis | |
| Mycoses | |
| Protozoan Infections | |
| Schistosomiasis | |
| Species Specificity | |
| Virus Diseases |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36569657 | 4-Hydroxy-3-nitro-1,4-dihydrotriazolo[5,1-c][1,2,4]triazines: synthesis, antiviral activity, and electrochemical characteristics. | Russ Chem Bull | 2022 | https://conductscience.org/library/papers/36569657 | PubMed |
| 34443674 | Redox Conversions of 5-Methyl-6-nitro-7-oxo-4,7-dihydro-1,2,4triazolo[1,5-a]pyrimidinide L-Arginine Monohydrate as a Promising Antiviral Drug. | Molecules | 2021 | https://conductscience.org/library/papers/34443674 | PubMed |
| 24776300 | Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects. | Trends Parasitol | 2014 | https://conductscience.org/library/papers/24776300 | PubMed |
| 24165190 | Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24165190 | PubMed |
| 23946481 | An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23946481 | PubMed |
| 20679506 | Trypanocidal activity of aziridinyl nitrobenzamide prodrugs. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20679506 | PubMed |
| 20028822 | Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20028822 | PubMed |
| 18367671 | A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18367671 | PubMed |
| 6721462 | Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6721462 | PubMed |
| 6714854 | Antimicrobial effects of esters and amides of 3-(5-nitro-2-furyl)acrylic acid. | Folia Microbiol (Praha) | 1984 | https://conductscience.org/library/papers/6714854 | PubMed |
| 4451351 | Susceptibility of an insect Leptomonas and Crithidia fasciculata to several established antitrypanosomatid agents. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4451351 | PubMed |
| 3800344 | Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3800344 | PubMed |
| 2998746 | Structure-activity relationships in the free-radical metabolism of xenobiotics. | Environ Health Perspect | 1985 | https://conductscience.org/library/papers/2998746 | PubMed |
| 2729935 | Antibacterial activities of the antiparasitic drugs nifurtimox and benznidazole. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2729935 | PubMed |
| 1083712 | Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1083712 | PubMed |
| 810079 | Antibacterial activity of nitropyrroles, nitrothiphenes, and aminothiophenes in vitro. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/810079 | PubMed |
| 791102 | Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/791102 | PubMed |
| 646342 | Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/646342 | PubMed |
| 626487 | Absence of strand breaks in deoxyribonucleic acid treated with metronidazole. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/626487 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4584690
GET https://conductscience.org/api/papers/v1/4584690/authors